Skip to content

MOLN

Molecular Partners AG

NASDAQ · Healthcare · Biotechnology · CH

$4.21
+7.40%
Ask drillr

Next report

Analyst consensus

Next report date
Oct 29, 2026
EPS estimate
-$0.46
Revenue estimate

Latest reported

Last report date
Aug 25, 2026
EPS actual
-$0.44
EPS estimate
-$0.45
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
5
EPS misses (12Q)
4
EPS in line (12Q)
0
Avg surprise (4Q)
-2.0%
Revenue beats (12Q)
3
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 25, 2026-$0.45-$0.44Beat 2.22%
May 12, 2026-$0.38-$0.45Miss -18.42%
Mar 12, 2026-$0.40-$0.41Miss -2.47%
Oct 30, 2025-$0.46-$0.41Beat 10.87%
Aug 25, 2025-$0.53-$0.67Miss -26.42%
May 15, 2025-$0.42-$0.50Miss -18.64%
Mar 6, 2025-$0.44-$0.34Beat 22.73%
Oct 31, 2024-$0.63-$0.57Beat 9.52%$810.2K
May 16, 2024-$0.39$3.0M
Mar 14, 2024-$0.97-$0.68Beat 29.90%$1.2M
Oct 26, 2023-$0.40$2.8M
Aug 23, 2023-$0.55$462.7K

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026